Division of Mucosal Immunology & Diagnostics, Priority Program Asthma & Allergy, Research Center Borstel, Leibniz Center for Medicine and Biosciences, Parkallee 22, 23845 Borstel, Germany, Member of the German Center for Lung Research.
Beilstein J Nanotechnol. 2014 Dec 2;5:2308-15. doi: 10.3762/bjnano.5.239. eCollection 2014.
Anthropogenic nanoparticles (NPs) have found their way into many goods of everyday life. Inhalation, ingestion and skin contact are potential routes for NPs to enter the body. In particular the digestive tract with its huge absorptive surface area provides a prime gateway for NP uptake. Considering that NPs are covered by luminal gut-constituents en route through the gastrointestinal tract, we wanted to know if such modifications have an influence on the interaction between NPs and enterocytes.
We investigated the consequences of a treatment with various luminal gut-constituents on the adherence of nanoparticles to intestinal epithelial cells. Carboxylated polystyrene particles 20, 100 and 200 nm in size represented our anthropogenic NPs, and differentiated Caco-2 cells served as model for mature enterocytes of the small intestine. Pretreatment with the proteins BSA and casein consistently reduced the adherence of all NPs to the cultured enterocytes, while incubation of NPs with meat extract had no obvious effect on particle adherence. In contrast, contact with intestinal fluid appeared to increase the particle-cell interaction of 20 and 100 nm NPs.
Luminal gut-constituents may both attenuate and augment the adherence of NPs to cell surfaces. These effects appear to be dependent on the particle size as well as on the type of interacting protein. While some proteins will rather passivate particles towards cell attachment, possibly by increasing colloid stability or camouflaging attachment sites, certain components of intestinal fluid are capable to modify particle surfaces in such a way that interactions with cellular surface structures result in an increased binding.
人为纳米粒子(NPs)已经在许多日常生活用品中被发现。吸入、摄入和皮肤接触是 NPs 进入人体的潜在途径。特别是具有巨大吸收表面积的消化道为 NPs 的摄取提供了主要途径。考虑到 NPs 在通过胃肠道的过程中被肠道腔内成分所覆盖,我们想知道这些修饰是否会影响 NPs 与肠上皮细胞的相互作用。
我们研究了用各种肠道腔内成分处理对纳米颗粒与肠上皮细胞黏附的影响。大小为 20、100 和 200nm 的羧基化聚苯乙烯颗粒代表我们的人为 NPs,分化的 Caco-2 细胞作为小肠成熟肠上皮细胞的模型。BSA 和酪蛋白的预处理一致降低了所有 NPs 与培养的肠上皮细胞的黏附,而 NPs 与肉浸液孵育对颗粒黏附没有明显影响。相比之下,与肠液接触似乎增加了 20nm 和 100nm NPs 与细胞的相互作用。
肠道腔内成分可能会减弱和增强 NPs 与细胞表面的黏附。这些影响似乎取决于颗粒大小以及相互作用的蛋白质类型。虽然一些蛋白质会通过增加胶体稳定性或掩盖附着部位而使颗粒对细胞附着产生钝化作用,但肠液的某些成分能够修饰颗粒表面,从而与细胞表面结构相互作用导致结合增强。